<DOC>
	<DOCNO>NCT02962791</DOCNO>
	<brief_summary>Cardiac resynchronization therapy ( CRT ) recommend treatment select patient symptomatic heart failure ( HF ) . Although treated patient show benefit CRT , lack response observe 25-30 % whatever response criterion use either base clinical status ( NYHA class , Packer clinical composite score ) ventricular remodel parameter assess echography ( Left ventricle end systole volume ) . This rate remain remarkably stable since therapy start motivate many study well understand underlie physiopathology CRT action mechanism . Among various research ax improve CRT response responder rate , increase number pacing site attempt good homogenize cardiac mechanical activity evaluate . A configuration two RV lead one LV lead test acutely three study . In case , demonstrate significant improvement cardiac performance whether assessed echographic parameter LV dp/dt measurement . Additionally feasibility approach long term CRT delivery demonstrate previous study . First result triple-site ventricular stimulation encourage clinical efficacy test large population order conclude interest CRT candidate .</brief_summary>
	<brief_title>Prospective Randomized Trial Comparing TRIPLE Site ventriculAr Stimulation Versus Conventional Pacing CRT canDidates</brief_title>
	<detailed_description />
	<criteria>Patient sign MEC approve informed consent Patient old 18 Patient CRT ( CRTP D ) indication per ESC guideline 2013 Left Ventricular Ejection Fraction ( LVEF ) ≤ 35 % NYHA class II/III/IV despite optimal medical treatment Left Bundle Branch Block ( LBBB ) QRS ≥ 120 m ( class IA IB indication ) absence LBBB QRS &gt; 150 m ( class IIA indication ) De novo implantation Sinus rhythm Permanent supra ventricular tachycardia Pacing indication 3rd degree AV block Impossibility perform FU investigative center Pregnancy Adults legal protection Heart transplant candidate Concomitant pathology may interfere study result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>symptomatic heart failure</keyword>
</DOC>